ATE68600T1 - Satz und verfahren zur diagnose der iganephropathie. - Google Patents

Satz und verfahren zur diagnose der iganephropathie.

Info

Publication number
ATE68600T1
ATE68600T1 AT88904694T AT88904694T ATE68600T1 AT E68600 T1 ATE68600 T1 AT E68600T1 AT 88904694 T AT88904694 T AT 88904694T AT 88904694 T AT88904694 T AT 88904694T AT E68600 T1 ATE68600 T1 AT E68600T1
Authority
AT
Austria
Prior art keywords
diagnosis
pct
substrate
iga
complex
Prior art date
Application number
AT88904694T
Other languages
English (en)
Inventor
Bo Cederholm
Joergen Wieslander
Per Bygren
Dick Heinegard
Original Assignee
Biocarb Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocarb Ab filed Critical Biocarb Ab
Application granted granted Critical
Publication of ATE68600T1 publication Critical patent/ATE68600T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT88904694T 1987-05-08 1988-05-09 Satz und verfahren zur diagnose der iganephropathie. ATE68600T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8701905A SE461616B (sv) 1987-05-08 1987-05-08 Foerfarande och testsats vid diagnos av iga nefropati med bestaemning av fibronektin-iga-komplex
PCT/SE1988/000240 WO1988008983A1 (en) 1987-05-08 1988-05-09 A METHOD AND A KIT FOR THE DIAGNOSIS OF IgA NEPHROPATHY
EP88904694A EP0363397B1 (de) 1987-05-08 1988-05-09 Satz und verfahren zur diagnose der iga-nephropathie

Publications (1)

Publication Number Publication Date
ATE68600T1 true ATE68600T1 (de) 1991-11-15

Family

ID=20368457

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88904694T ATE68600T1 (de) 1987-05-08 1988-05-09 Satz und verfahren zur diagnose der iganephropathie.

Country Status (7)

Country Link
US (1) US5139932A (de)
EP (1) EP0363397B1 (de)
JP (1) JP2592121B2 (de)
AT (1) ATE68600T1 (de)
DE (1) DE3865678D1 (de)
SE (1) SE461616B (de)
WO (1) WO1988008983A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04502363A (ja) * 1988-12-12 1992-04-23 バード　ダイアグノスティック　サイエンシズ，インコーポレイティド 癌及びその他の疾病の診断としての基底膜成分の検出
US5246835A (en) * 1991-05-24 1993-09-21 Wakamoto Pharmaceutical Co., Ltd. Method of diagnosing renal diseases
US20060281681A1 (en) 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
US6255281B1 (en) * 1997-05-28 2001-07-03 Claragen, Inc. And U.S. Government Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
US7122344B2 (en) 1997-05-28 2006-10-17 Claragen, Inc. Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
DE69938780D1 (de) 1998-03-31 2008-07-03 Asahi Kasei Pharma Corp VERFAHREN ZUR UNTERSUCHUNG DER IgA-NEPHROPATHIE
WO2002006346A1 (en) * 2000-07-19 2002-01-24 Battelle Memorial Institute ASSAY FOR IDENTIFYING υ2u-GLOBULIN-MEDIATED NEPHROPATHY
FI20010868A0 (fi) * 2001-04-25 2001-04-25 Markku Maeki Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi
WO2007019376A2 (en) 2005-08-03 2007-02-15 Rq Bioscience, Inc. Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
US8426142B2 (en) 2008-06-02 2013-04-23 Eisai R&D Management Co., Ltd. IgA nephropathy testing method and test kit
KR20110022622A (ko) 2008-06-02 2011-03-07 에자이 알앤드디 매니지먼트 가부시키가이샤 ＩｇＡ 신증의 검사 방법 및 검사 키트
EP2442105B1 (de) 2009-06-10 2015-01-07 Niigata University Testverfahren für Nierenerkrankungen
WO2012098449A1 (en) 2011-01-17 2012-07-26 University Of Manitoba Methods for treating disorders that involve immunoglobulin a
US9598733B2 (en) 2011-02-17 2017-03-21 The Trustees Of Columbia University In The City Of New York Methods for identifying subjects with a genetic risk for developing IgA nephropathy
US10202647B2 (en) 2013-04-12 2019-02-12 The Trustees Of Columbia University In The City Of New York Mutations in DSTYK cause dominant urinary tract malformations
JP7473398B2 (ja) 2020-05-28 2024-04-23 シスメックス株式会社 キャリブレータ、複合体、及びＩｇＡ凝集体を測定する方法

Also Published As

Publication number Publication date
WO1988008983A1 (en) 1988-11-17
DE3865678D1 (de) 1991-11-21
EP0363397A1 (de) 1990-04-18
US5139932A (en) 1992-08-18
SE8701905D0 (sv) 1987-05-08
JPH02503714A (ja) 1990-11-01
SE8701905L (sv) 1988-11-09
EP0363397B1 (de) 1991-10-16
JP2592121B2 (ja) 1997-03-19
SE461616B (sv) 1990-03-05

Similar Documents

Publication Publication Date Title
ATE68600T1 (de) Satz und verfahren zur diagnose der iganephropathie.
MX9801687A (es) Compuestos y metodos para el diagnostico de tuberculosis.
TR200000113T2 (tr) Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri.
SE7906148L (sv) Forfarande for framstellning av en biologisk komposition for anvendning sasom referenskontroll vid diagnostiska tester
DE69412137T2 (de) Sensoreinrichtung zum sandwichtest
ATE223051T1 (de) Verfahren zur diagnose gutartiger prostataerkrankungen
ATE123653T1 (de) Vernetzte antikörper und verfahren zu ihrer herstellung.
DE3750046D1 (de) Angiographisches Verfahren mittels magnetischer Kernresonanz und Gerät zur Durchführung dieses Verfahrens.
NO991693L (no) Forbindelser og metoder for diagnose av tuberkulose
ATE223435T1 (de) Verfahren zur diagnose von störungen durch bestimmung der expression von gage- tumorabstossungsantigen-vorläufern
DE69531345D1 (de) Rekombinant pgp3, verfahren zu dessen herstellung, und dessen verwendung in der diagnose und therapie
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
WO1995005604A3 (en) Methods for the diagnosis of alzheimer's disease
ATE192238T1 (de) Verfahren und gerät zum nachweis einer mycobacterium spezies verantwortlich für eine mycobacterium infektion
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
DE69020182D1 (de) Vernetzte Antikörper und Verfahren zu ihrer Herstellung.
DE69122761T2 (de) Verfahren und komposition zum frühnachweiss und behandlung insulinabhängiger diabetes
DE68921374D1 (de) Monoklonaler Antikörper gegen menschliche Mangan-Superoxiddismutase, Verfahren zu dessen Herstellung, Testreagens, Kit und Testmethode unter Verwendung desselben, Verfahren zur Diagnose von menschlichem Eierstockkrebs und von Herzinfarkt.
ATE126599T1 (de) Verfahren zur bestimmung von anti-rns- antikörpern.
DE69014201T2 (de) Verfahren und testsatz zur bestimmung von tyrosinphosphorylierungs- und dephosphorylierungsaktivitäten.
DE69226775D1 (de) Dns-sequenzen von hpv42 papillomavirus :verwendungsmöglichkeit für diagnose
DE69839876D1 (de) Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung
DE69123723D1 (de) Diagnostisches verfahren und reagenz für hiv
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
DE69523492D1 (de) Immunoassay-Reagenzien, Testsätze und Verfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties